{
    "title": "Genmab and J&J 'love' partnership as some ponder takeover",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5132335/Genmab-J-J-love-partnership-ponder-takeover.html",
    "date": "2017-11-30",
    "keywords": [
        "jampj",
        "genmab",
        "company",
        "actelion",
        "success",
        "drug",
        "hirschler",
        "biotech",
        "johnson",
        "antibody",
        "royalty",
        "jampjs",
        "group",
        "disease",
        "decision",
        "part",
        "london",
        "partner",
        "year",
        "specialist",
        "spot",
        "fate",
        "soaraway",
        "blood",
        "cancer",
        "percent",
        "money",
        "bernstein",
        "analyst",
        "team",
        "relationship",
        "partnership",
        "chief",
        "officer",
        "paul",
        "interest",
        "capital",
        "strategy",
        "stream",
        "wave",
        "treatment",
        "myeloma",
        "promise",
        "trial",
        "amyloidosis",
        "buildup",
        "protein",
        "payment",
        "executive",
        "jan",
        "sale",
        "business",
        "future",
        "operation",
        "focus",
        "innovation",
        "powerhouse",
        "value",
        "entity",
        "interview",
        "van",
        "winkel",
        "need",
        "revenue",
        "hole",
        "remicade",
        "income",
        "reason",
        "ben",
        "editing",
        "croft"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}